Drug recall · January 14, 2026
Rosuvastatin Tablets recall
Why: Out of specification for dissolution.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Rosuvastatin Tablets, USP, 10 mg, Rx Only, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKARE, Pulaski, TN 38478. NDC: 50268-709-15
- Lots / codes
Lot #49124, Exp Date 12/31/2026
- Quantity
- 7,991 5x10 cartons
- Company
- AvKARE, Pulaski, TN
- Distribution
- Nationwide in the USA
- Initiated
- December 31, 2025 · Voluntary: Firm initiated
- Classified
- January 20, 2026
- Reported
- January 14, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Rosuvastatin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.